In This Section

All Advocacy

Keep up with breaking news on policy decisions and legislation affecting biomedical research, research funding opportunities, regulations, and other important matters impacting pharmacology and pharmacologists.

Refine Results
  • icon-advocacy-statement April 10, 2017 ASPET Joins 286 Organizations in Urging Congress to Act on Current Spending and Reject Proposed R&D Cuts
    April 6, 2017 Senator Mitch McConnell Senator Charles Schumer Senate Majority Leader Senate Minority Leader U.S. Senate U.S. Senate The Honorable Paul Ryan Minority Leader Nancy Pelosi Speaker of the House Democratic Leader U.S. House of Representatives U.S. House of Representatives Dear Congressional Leaders: The undersigned U.S. business, science and e
  • icon-advocacy-news March 31, 2017 March 31, 2017: ASPET Government Affairs and Science Policy Update
    Trump Administration proposes $1.2 billion cut to NIG grants in 2017 in the midst of 2018 blueprint uproar; Freedom Caucus may obstruct spending package; House Approps. holds hearing on HHS funding; Grant applicants can now cite Preprints  FY 2017 Appropriations: With the government currently operating on a continuing resolution set to expire on April 28, Congress must approve a budget b…
  • March 28, 2017 NIH Issue Final Policy on Reporting Preprints in Grant Applications and Progress Reports
    On March 24, NIH issued a Notice stating that the agency will allow investigators to report preprints and other interim research products in grant applications and Research Performance Progress Reports (RPPRs) submitted on or after May 25, 2017. Highlights include: Citation format: Citations for preprints and other interim research products must include the Digital Object Identifier [DOI], Ob…
  • March 17, 2017 ASPET Statement in Response to the President Trump’s Fiscal Year (FY) 2018 Budget Blueprint
    AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 9650 Rockville Pike | Bethesda | MD | 20814-3995 P: (301) 634-7060 | F: (301) 634-7061 | E: info@aspet.org | www.aspet.org For Immediate Release Contact: Susanna Aguirre 301-634-7062 saguirre@aspet.org ASPET Statement in Response to the President Trumps Fiscal Year (FY) 2018 Budget Blueprint BETHESDA Th
  • icon-advocacy-news March 3, 2017 March 3, 2017: ASPET Government Affairs and Science Policy Update
    Appropriations bills on the move; Renewed interest in closing out FY2017 spending bills; Labor HHS holds hearing on budget priorities  House Labor-HHS Subcommittee Hearing: The House Labor-HHS Subcommittee held a hearing this week for Members of Congress to testify about their funding priorities yesterday. Chairman Tom Cole wasted no time throwing cold water on expectations for FY 2018, notin…
  • February 17, 2017 February 17, 2017: ASPET Government Affairs and Science Policy Update
    More Cabinet confirmations; FY17 drumbeat continues; Appropriators consider FY18 spending priorities; POTUS “skinny budget” expected in March  House begins preliminary work on FY2018 appropriations:  House Appropriations Committee Chairman Rodney Frelinghuysen (R-NJ) announced that all subcommittees will be holding “Member Day” hearings to “allow each Member…
  • icon-advocacy-news February 7, 2017 February 3, 2017: ASPET Government Affairs and Science Policy Update
    Congress still discussing process for completing 2017 spending bills; Senate Appropriations panel finalizes rosters; Trump Cabinet nominees considered by Committees with research funding discussed  House Appropriations Committee leaders are beginning conversations about how to fund government agencies for the remainder of fiscal year (FY) 2017 after the current “continuing resolution&rd…
  • February 3, 2017 ASPET Joins 164 Leading Scientific Groups in AAAS Letter Addressing Immigration Executive Order
    February 10, 2017 President Donald J. Trump The White House United States of America Dear President Trump: The January 27, 2017, White House Executive Order on visas and immigration has profound implications for diplomatic, humanitarian, and national security interests, in part because of the negative impact on U.S. science and engineering capacity. The 182 und
  • icon-advocacy-statement February 1, 2017 ASPET Urges Congressional Leadership to Pass 2017 Spending Package Without Delay
    AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Transforming Discoveries into Therapies ASPET 9650 Rockville Pike Bethesda, Maryland 20814 Office: 301-634-7060 aspet.org President Donald J. Trump The White House Washington, DC 20500 The Honorable Mitch McConnell Majority Leader US Senate S-230, The Capitol Washington, DC 20510 The Honorabl
  • February 1, 2017 ASPET Statement on Executive Order Addresses Implications for Members, Biomedical Research Community
    AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 9650 Rockville Pike | Bethesda | MD | 20814-3995 P: (301) 634-7060 | F: (301) 634-7061 | E: info@aspet.org | www.aspet.org For Immediate Release Contact: Susanna Aguirre 301-634-7062 saguirre@aspet.org ASPET Statement on Executive Order Restricting Immigration BETHESDA The American Society f
Last Updated: September 20, 2017

Job Postings